Quantitative magnetic resonance mapping of the myelin bilayer reflects pathology in multiple sclerosis brain tissue.


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
11 08 2023
Historique:
medline: 14 8 2023
pubmed: 11 8 2023
entrez: 11 8 2023
Statut: ppublish

Résumé

Multiple sclerosis (MS) is a neuroinflammatory disease characterized by loss of myelin (demyelination) and, to a certain extent, subsequent myelin repair (remyelination). To better understand the pathomechanisms underlying de- and remyelination and to monitor the efficacy of treatments aimed at regenerating myelin, techniques offering noninvasive visualizations of myelin are warranted. Magnetic resonance (MR) imaging has long been at the forefront of efforts to visualize myelin, but it has only recently become feasible to access the rapidly decaying resonance signals stemming from the myelin lipid-protein bilayer itself. Here, we show that direct MR mapping of the bilayer yields highly specific myelin maps in brain tissue from patients with MS. Furthermore, examination of the bilayer signal behavior is found to reveal pathological alterations in normal-appearing white and gray matter. These results indicate promise for in vivo implementations of the myelin bilayer mapping technique, with prospective applications in basic research, diagnostics, disease monitoring, and drug development.

Identifiants

pubmed: 37566661
doi: 10.1126/sciadv.adi0611
pmc: PMC10421026
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

eadi0611

Références

Neuroimage. 2017 Dec;163:358-367
pubmed: 28964929
Magn Reson Med. 1994 Jun;31(6):673-7
pubmed: 8057820
Physiol Rev. 2019 Jul 1;99(3):1381-1431
pubmed: 31066630
Lancet Neurol. 2019 Feb;18(2):198-210
pubmed: 30663609
Nat Commun. 2021 May 19;12(1):2941
pubmed: 34011929
Radiology. 2020 Nov;297(2):392-404
pubmed: 32779970
Lancet Neurol. 2020 Aug;19(8):678-688
pubmed: 32702337
Magn Reson Med. 2018 Jun;79(6):3256-3266
pubmed: 28983969
J Intern Med. 2021 Jun;289(6):771-791
pubmed: 33258193
Neurotherapeutics. 2007 Jul;4(3):460-84
pubmed: 17599712
Proc Natl Acad Sci U S A. 2012 Jun 12;109(24):9605-10
pubmed: 22628562
Nat Rev Drug Discov. 2019 Dec;18(12):905-922
pubmed: 31399729
NMR Biomed. 2020 Oct;33(10):e4326
pubmed: 32691472
J Magn Reson. 2021 Feb;323:106909
pubmed: 33453678
Magn Reson Med. 2011 Jul;66(1):24-31
pubmed: 21574183
Nat Rev Neurol. 2015 Mar;11(3):134-42
pubmed: 25686758
Brain Plast. 2016 Dec 21;2(1):71-91
pubmed: 29765849
Magn Reson Imaging. 2022 Feb;86:107-117
pubmed: 34906631
J Neurosci. 2011 Feb 16;31(7):2382-90
pubmed: 21325505
Magn Reson Med. 2020 Oct;84(4):1933-1946
pubmed: 32176828
Magn Reson Med. 2021 Feb;85(2):627-652
pubmed: 32936494
Magn Reson Med. 2023 Feb;89(2):508-521
pubmed: 36161728
NMR Biomed. 2021 Jun;34(6):e4493
pubmed: 33624305
Magn Reson Med. 2015 Feb;73(2):614-22
pubmed: 24604578
Ann Neurol. 2011 Nov;70(5):764-73
pubmed: 22162059
Prog Nucl Magn Reson Spectrosc. 2019 Oct - Dec;114-115:237-270
pubmed: 31779882
Magn Reson Med. 2023 Feb;89(2):665-677
pubmed: 36253953
Neuroimage. 2016 Aug 1;136:37-44
pubmed: 27155128
Lancet Neurol. 2021 Aug;20(8):653-670
pubmed: 34139157
J Magn Reson A. 1996 Nov;123(1):131-4
pubmed: 8980075
Neuroimage. 2020 Aug 15;217:116888
pubmed: 32360688
Invest Radiol. 2021 Nov 1;56(11):773-784
pubmed: 34120128
Quant Imaging Med Surg. 2020 May;10(5):895-906
pubmed: 32489915
J Magn Reson. 2016 Feb;263:147-155
pubmed: 26796113
Neuroimage. 2014 Feb 15;87:32-41
pubmed: 24188809
Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9304-9
pubmed: 16754874
Magn Reson Med. 2019 Oct;82(4):1504-1517
pubmed: 31125149
Magn Reson Med. 2016 Apr;75(4):1831-40
pubmed: 25975352
Chem Phys Lipids. 1975 Apr;14(2):107-12
pubmed: 1126007
Neuron. 2022 Nov 2;110(21):3549-3565
pubmed: 36228613
Magn Reson Med. 2018 Aug;80(2):538-547
pubmed: 29271083

Auteurs

Emily Louise Baadsvik (EL)

Institute for Biomedical Engineering, ETH Zurich and University of Zurich, Zurich, Switzerland.

Markus Weiger (M)

Institute for Biomedical Engineering, ETH Zurich and University of Zurich, Zurich, Switzerland.

Romain Froidevaux (R)

Institute for Biomedical Engineering, ETH Zurich and University of Zurich, Zurich, Switzerland.

Wolfgang Faigle (W)

Neuroimmunology and MS Research Section, Neurology Clinic, University of Zurich, University Hospital Zurich, Zurich, Switzerland.
Institut Curie, Immunity and Cancer Unit 932, Paris, France.

Benjamin V Ineichen (BV)

Department of Neuroradiology, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Center for Reproducible Science, University of Zurich, Zurich, Switzerland.

Klaas P Pruessmann (KP)

Institute for Biomedical Engineering, ETH Zurich and University of Zurich, Zurich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH